Paul Elliot Mann Sells 316,666 Shares of ASP Isotopes Inc. (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CEO Paul Elliot Mann sold 316,666 shares of the company’s stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $1,779,662.92. Following the transaction, the chief executive officer now directly owns 7,315,454 shares of the company’s stock, valued at $41,112,851.48. This trade represents a 4.15 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Paul Elliot Mann also recently made the following trade(s):

• On Tuesday, April 15th, Paul Elliot Mann sold 316,667 shares of ASP Isotopes stock. The stock was sold at an average price of $5.75, for a total value of $1,820,835.25.

ASP Isotopes Stock Up 2.6 %

ASP Isotopes stock opened at $5.84 on Friday. The firm has a market capitalization of $420.88 million, a P/E ratio of -9.57 and a beta of 3.44. The company has a 50-day simple moving average of $4.74 and a 200-day simple moving average of $5.15. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.33. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

Institutional Investors Weigh In On ASP Isotopes

A number of hedge funds have recently made changes to their positions in ASPI. Hanson & Doremus Investment Management acquired a new stake in ASP Isotopes in the 4th quarter valued at approximately $27,000. BNP Paribas Financial Markets acquired a new position in shares of ASP Isotopes during the fourth quarter valued at $34,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of ASP Isotopes during the third quarter valued at about $42,000. Avantax Advisory Services Inc. acquired a new stake in ASP Isotopes in the fourth quarter worth about $45,000. Finally, Russell Investments Group Ltd. increased its stake in ASP Isotopes by 56.3% during the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock valued at $46,000 after buying an additional 3,682 shares during the period. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.